{"id":"https://openalex.org/W3129746992","doi":"https://doi.org/10.1158/1538-7445.sabcs20-ps13-34","title":"Abstract PS13-34: Differential efficacy of pegfilgrastim (Peg) in patients (pts) with breast cancer (BC) versus other cancer types for the prevention of docetaxel (Doc) chemotherapy-induced neutropenia (CIN)","display_name":"Abstract PS13-34: Differential efficacy of pegfilgrastim (Peg) in patients (pts) with breast cancer (BC) versus other cancer types for the prevention of docetaxel (Doc) chemotherapy-induced neutropenia (CIN)","publication_year":2021,"publication_date":"2021-02-15","ids":{"openalex":"https://openalex.org/W3129746992","doi":"https://doi.org/10.1158/1538-7445.sabcs20-ps13-34","mag":"3129746992"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs20-ps13-34","doi":"https://doi.org/10.1158/1538-7445.sabcs20-ps13-34","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs20-ps13-34","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061736755","display_name":"Douglas W. Blayney","orcid":"https://orcid.org/0000-0002-7931-4533","observed_orcids":["https://orcid.org/0000-0002-7931-4533"]},"institutions":[{"id":"https://openalex.org/I4390039303","display_name":"Stanford Cancer Institute","ror":"https://ror.org/014qe3j22","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I4390039303","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Douglas W. Blayney","raw_affiliation_strings":["1Stanford Cancer Institute, Stanford, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Stanford Cancer Institute, Stanford, CA;","institution_ids":["https://openalex.org/I4390039303","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Greg Ginn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Greg Ginn","raw_affiliation_strings":["2Statogen Consulting,LLC, Research Triangle Park, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Statogen Consulting,LLC, Research Triangle Park, NC;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070754234","display_name":"Lan Huang","orcid":"https://orcid.org/0000-0002-3140-4687","observed_orcids":["https://orcid.org/0000-0002-3140-4687"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lan Huang","raw_affiliation_strings":["3Beyond Spring Pharmaceuticals, Inc, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Beyond Spring Pharmaceuticals, Inc, New York, NY;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015687794","display_name":"Ramon W. Mohanlal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ramon Mohanlal","raw_affiliation_strings":["4Beyond Spring Pharmaceuticals,Inc., New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Beyond Spring Pharmaceuticals,Inc., New York, NY","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"81","issue":"4_Supplement","first_page":"PS13","last_page":"34"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12919","display_name":"Blood disorders and treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pegfilgrastim","display_name":"pegfilgrastim","score":0.9929999709129333},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.8840000033378601},{"id":"https://openalex.org/keywords/chemotherapy-induced-neutropenia","display_name":"chemotherapy-induced neutropenia","score":0.9929999709129333},{"id":"https://openalex.org/keywords/neutropenia-prophylaxis","display_name":"neutropenia prophylaxis","score":0.890999972820282},{"id":"https://openalex.org/keywords/plinabulin","display_name":"plinabulin","score":0.9309999942779541},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9800000190734863},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9819999933242798},{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.9070000052452087},{"id":"https://openalex.org/keywords/tac-chemotherapy","display_name":"TAC chemotherapy","score":0.6150000095367432},{"id":"https://openalex.org/keywords/neutrophil-count","display_name":"neutrophil count","score":0.5389999747276306},{"id":"https://openalex.org/keywords/febrile-neutropenia","display_name":"febrile neutropenia","score":0.7059999704360962}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8793920278549194},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.7858397960662842},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.7823269367218018},{"id":"https://openalex.org/C2778658803","wikidata":"https://www.wikidata.org/wiki/Q1592932","display_name":"Pegfilgrastim","level":5,"score":0.6453375220298767},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5978637933731079},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5794310569763184},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.5397980213165283},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4979574680328369},{"id":"https://openalex.org/C54400483","wikidata":"https://www.wikidata.org/wiki/Q1793202","display_name":"PEG ratio","level":2,"score":0.48317328095436096},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.445840060710907},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4407050311565399},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4121280610561371},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3611770570278168},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs20-ps13-34","doi":"https://doi.org/10.1158/1538-7445.sabcs20-ps13-34","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs20-ps13-34","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3131553692","https://openalex.org/W4391808024","https://openalex.org/W4206195540","https://openalex.org/W3095561524","https://openalex.org/W3171922292","https://openalex.org/W3129386684","https://openalex.org/W4414254787","https://openalex.org/W3171295247","https://openalex.org/W2984749858","https://openalex.org/W2978491094"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"Peg":[2,67,99,116,153,229,340,346,362,405,412],"and":[3,79,132,161,187,211,233],"other":[4,459],"G-CSFs":[5],"are":[6,39],"widely":[7],"used":[8],"in":[9,28,41,72,81,106,122,166,178,185,202,208,223,227,260,265,280,290,305,315,369,382,393,399,414,426,432,451],"BC":[10,34,108,123,209,248,266,281,291,306,322,336,400,415,433],"patients":[11,452],"receiving":[12,36,215,417],"myelosuppressive":[13],"chemotherapy.":[14],"We":[15],"previously":[16],"reported":[17],"that":[18,97],"Peg\u2019s":[19],"mechanism":[20],"of":[21,31,75,181,189,192,238,246,330,361,372,379,385,391,396,448,465,474],"action":[22],"(MoA)":[23],"for":[24,168,351,462],"CIN":[25,56,71,103,119,352,409],"-prevention":[26],"protects":[27],"week":[29,42,73,370,383,394],"2":[30,371],"the":[32,54,76,89,224,228,373,386,397,427,463,475],"cycle.":[33,91],"pts":[35,136,214,222,237,249,267,270,282,292,307,317,323,326,337,380,416,434],"Doc/Doxorubicin/Cyclophosphamide":[37],"(TAC)":[38],"unprotected":[40,381],"1.":[43],"[Study":[44],"BPI-2358-106":[45],"(NCT03102606)":[46,113],"Blayney,":[47,439],"St":[48],"Gallen":[49],"2019].":[50],"In":[51,110,126,335],"this":[52],"study,":[53],"novel":[55],"agent":[57],"Plinabulin":[58,392],"(Plin),":[59],"with":[60,83,137,151,277,318,332,339,404,454],"a":[61,101,376],"MoA":[62],"different,":[63],"yet":[64],"complimentary":[65],"to":[66,204,355,365],"CIN,":[68],"prevented":[69],"severe":[70],"1":[74,140,384,395],"Cycle":[77,398],"(C),":[78],"given":[80],"combination":[82],"Pegflgrastim,":[84],"offered":[85],"superior":[86,408],"protection":[87,367,410],"throughout":[88],"entire":[90],"Other":[92],"Study":[93,111,127],"106":[94],"results":[95],"indicated":[96],"monotherapy":[98,117,341],"is":[100,347],"sub-optimal":[102,359],"prophylaxis":[104],"strategy":[105],"TAC-treated":[107],"pts.":[109,124,295,357],"BPI-2358-105":[112],"we":[114],"evaluated":[115],"as":[118,143],"preventive":[120],"therapy":[121],"Methods:":[125],"105,":[128],"BC,":[129],"lung":[130],"(NSCLC)":[131],"prostate":[133],"cancer":[134,456,460],"(HRPC)":[135],"at":[138],"least":[139],"risk":[141],"factor":[142],"per":[144],"NCCN":[145],"guidelines,":[146],"received":[147],"Doc":[148,216,343],"75":[149,217,344],"mg/m2":[150],"either":[152],"6mg":[154],"(n=53)":[155],"or":[156],"Plin":[157,428],"40":[158],"mg":[159],"(n=52),":[160],"had":[162,327],"frequent":[163],"blood":[164],"draws":[165],"C1":[167,203,261],"Neutrophil":[169],"count":[170],"assessment.":[171],"Grade":[172],"(Gr)":[173],"4":[174,242,252,255,424],"Neutropenia":[175,183],"(N)":[176],"frequency":[177,188,257,425],"C1,":[179,186],"Duration":[180],"Severe":[182],"(DSN)":[184],"clinical":[190,328],"sequelae":[191,329],"N":[193,256,331],"(Hospitalizations,":[194],"Infections,":[195],"FN,":[196],"antibiotic":[197],"use,":[198],"chemotherapy":[199],"dose":[200],"reductions)":[201],"C4":[205],"were":[206,220],"calculated":[207],"(n=27)":[210],"NSCLC/HRPC":[212,269,294,316,325,356],"(n=26)":[213],"mg/m2.":[218],"There":[219],"9":[221],"HRPC":[225,232],"group":[226],"arm.":[230],"Results:No":[231],"4%":[234],"(1pt)":[235],"NSCLC":[236],"peg-treated":[239],"developed":[240,250],"Gr":[241,251,254,423],"N,":[243],"whereas":[244],"16%":[245],"Peg-treated":[247],"N.":[253],"over":[258],"time":[259],"was":[262,283,297,363,430],"significantly":[263,348],"higher":[264],"vs":[268,293,308,324,411],"(p<0.016;":[271],"Cochran-Mantel-Haenszel":[272],"test;":[273],"see":[274],"table":[275],"below)":[276],"Peg.":[278,319,333],"DSN":[279,296],">5":[284],"times":[285],"longer":[286],"(p<0.005;":[287],"NBR":[288],"test)":[289],"0.36":[298],"Day":[299,310],"(D)":[300],"(95%":[301,311],"CI:":[302,312],"0.28;":[303],"0.49)":[304],"0.076":[309],"0.03;":[313],"0.12)":[314],"Numerically":[320],"more":[321],"Conclusions:":[334],"treated":[338],"after":[342],"mg/m2,":[345],"less":[349],"effective":[350],"prevention":[353,464],"compared":[354],"The":[358,388],"efficacy":[360,447],"due":[364],"its":[366],"occurring":[368],"Cycle,":[374],"leaving":[375],"significant":[377],"number":[378],"Cycle.":[387],"demonstrated":[389],"effectiveness":[390],"pts,":[401],"when":[402],"combined":[403],"could":[406],"offer":[407],"alone":[413],"Doc.":[418],"Gr4N":[419],"%BaselineC1D1C1D2C1D6*C1D7C1D8C1D9C1D10C1D15BC0%0%0%16%12%4%4%4%0%NSCLC/":[420],"HRPC0%0%0%4%4%0%0%0%0%*On":[421],"C1D6,":[422],"arm":[429],"0%":[431],"Citation":[435],"Format:":[436],"Douglas":[437],"W.":[438],"Greg":[440],"Ginn,":[441],"Lan":[442],"Huang,":[443],"Ramon":[444],"Mohanlal.":[445],"Differential":[446],"pegfilgrastim":[449],"(Peg)":[450],"(pts)":[453],"breast":[455],"(BC)":[457],"versus":[458],"types":[461],"docetaxel":[466],"(Doc)":[467],"chemotherapy-induced":[468],"neutropenia":[469],"(CIN)":[470],"[abstract].":[471],"In:":[472],"Proceedings":[473],"2020":[476,483],"San":[477,486],"Antonio":[478],"Breast":[479],"Cancer":[480,492],"Virtual":[481],"Symposium;":[482],"Dec":[484],"8-11;":[485],"Antonio,":[487],"TX.":[488],"Philadelphia":[489],"(PA):":[490],"AACR;":[491],"Res":[493],"2021;81(4":[494],"Suppl):Abstract":[495],"nr":[496],"PS13-34.":[497]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2021-03-01T00:00:00"}